![]() |
|
|
,4
* Department of Nutritional Sciences and
Department of Microbiology and Molecular Immunology, Division of Animal Sciences, University of Missouri, Columbia, MO 65211; and
** Department of Pathological Sciences, State University of Londrina, Brazil
4To whom correspondence should be addressed. E-mail: FritscheK{at}missouri.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: (n-3) PUFA fatty acid infection Listeria T lymphocytes mice
Listeria monocytogenes is a ubiquitous, gram-positive bacteria that causes sepsis and meningitis in immunocompromised patients and a serious maternal/fetal infection in pregnant women (1,2). With a mortality rate of 2030%, listeriosis is the leading cause of death from all food-borne pathogens (3). Murine listeriosis has been used by many investigators as a model system to define the various factors and cells that are involved in the host response to intracellular pathogens (4,5). Cells of the innate immune system (e.g., macrophages, neutrophils, and natural killer cells) play a critical role in controlling bacterial growth during the initial stages of infection and direct the ensuing adaptive immune response (6,7). The adaptive immune response consists of pathogen-specific T lymphocytes that resolve acute infection and are capable of adoptively transferring protective immunity to a naive recipient (8). Long-term anti-listerial immunity is mediated by CD8+ memory T cells (9), which can be found in lymphoid and nonlymphoid tissues (10). This model provides an ideal framework for studies to determine how nutrition can affect innate and adaptive immune mechanisms associated with host resistance to infection from an intracellular pathogen.
(n-3) PUFA have anti-inflammatory and immunomodulatory activities (1115). Among the most well-documented effects of (n-3) PUFA are reductions in pro-inflammatory eicosanoid and cytokine production as well as T cell proliferation. Whereas some individuals suffering from various autoimmune and chronic inflammatory diseases may benefit from such changes, diminished inflammatory responses in others may impair infectious disease resistance (16). In fact, feeding mice a diet rich in (n-3) PUFA from fish oils makes them highly susceptible to infection from L. monocytogenes, as evidenced by diminished survival and impaired bacterial clearance (17,18). During murine listeriosis, high (n-3) PUFA intake is associated with substantial reductions in major histocompatibility complex expression (MHC)5 (19), and IL-12 and IFN
biosynthesis (20). These elements of the innate immune system are critical for host resistance against this pathogen (21,22). Given the strong symbiotic relation between innate and adaptive immune responses and the profound impairment of primary host resistance against L. monocytogenes, we hypothesized that dietary (n-3) PUFA would adversely affect the normal development of the adaptive immune response to this pathogen. Our previous investigation showed that, although high (n-3) PUFA intake was associated with severe impairment of primary host resistance against L. monocytogenes, the ability of surviving mice to generate protective immunity appeared to be mostly intact (23). The present investigation sought to determine more directly the impact of dietary (n-3) PUFA on in vivo adaptive T cell responses to L. monocytogenes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Bacteria.
Wild-type (10403S) and actA-deficient (DP-L3078) strains of L. monocytogenes were obtained as a generous gift from Daniel Portnoy, University of California-Berkeley, and were grown in tryptic soy broth at 37°C for 12 to 18 h prior to use. After 3 washes with sterile PBS (Life Technologies), the concentration of the bacteria was estimated via optical density and then diluted with PBS to the desired infectious dose. The actual dose administered in each experiment was confirmed by plate counts using blood agar plates. Bacterial challenges were given i.v. in a final volume of 0.2 mL PBS via the lateral tail vein. For primary challenge, 1 x 106 colony-forming units (CFU) of an attenuated strain of L. monocytogenes (i.e., actA-deficient L. monocytogenes) was used. This mutant strain of L. monocytogenes is unable to express functional actA protein; thus it cannot polymerize an actin tail and spread intracellularly to adjacent cells (25). Infection with this organism elicited a strong adaptive immune response, as reported by others (26). One important benefit of using an attenuated strain was to avoid the mortality in the (n-3) PUFA-fed animals noted in our previous studies (23). Thus, in the present study we eliminated the potential effect of survivor bias in our investigation of the adaptive immune response. Adoptive transfer recipients were challenged with 5 x 104 CFU of wild-type L. monocytogenes 10403S. For Listeria-specific IFN
assays, antigen-presenting cells (APC) were infected with freshly thawed L. monocytogenes 10403S from stock frozen and stored at 70°C in 50% solution of PBS and glycerol (Sigma). Bacterial loads in the spleen and liver were determined by plating 10-fold serial dilutions of tissue homogenates on Listeria-supportive McBride agar plates (Difco, BD).
Preparation of splenocytes. Spleens were removed from mice fed lard or fish oil diets at the indicated times after primary infection with actA-deficient L. monocytogenes. Mice were anesthetized, spleens aseptically removed, and splenocytes isolated as described previously (27). For cytokine capture assays splenocytes were resuspended in HEPES-buffered RPMI medium (Gibco BRL Products, Invitrogen) containing 100 mL/L fetal bovine serum (U.S. Bio-Technologies) and 2 mmol/L L-glutamine (herein referred to as complete medium). Prior to their use in adoptive transfer studies, splenocytes were resuspended in sterile PBS.
IFN
production by cytokine secretion assay.
Pathogen-specific IFN
production by CD4+ and CD8+ T cells was used as a marker to identify effector and memory/effector T lymphocytes. J774A.1 cells, a murine H2-Kd macrophage cell line (ATCC TIB 67; American Type Cell Culture), were infected with L. monocytogenes and used as APCs to elicit antigen-specific IFN
production. J774 cells maintained in complete RPMI 1640 medium without antibiotics were infected with L. monocytogenes 10403S at a multiplicity of infection of 10:1. After 25 min at 37°C, the infection was terminated by the addition of gentamycin (final concentration of 50 mg/L). APCs were incubated at 37°C for 4 h prior to the addition of splenocytes. At 7 or 35 d postchallenge with actA-deficient L. monocytogenes, effector or memory splenocyte preparations were isolated (respectively), and 5 x 106 cells were added at a 10:1 ratio to infected and uninfected (control) APCs in 48-well plates. For nonspecific stimulation, cells were cultured with low-endotoxin, plate-bound anti-CD3
and soluble anti-CD28 (both from SouthernBiotech). Regardless of stimuli, cells were cocultured for 16 h at 37°C and then harvested for the cytokine secretion assay. Cells were transferred to 50-mL conical centrifuge tubes, washed twice in cold PBS with 0.5% bovine serum albumin and 2 mmol/L EDTA (Sigma), and labeled with anti-IFN
catch reagent according to the manufacturers instructions (Miltenyi). Tubes were filled with warm medium, fixed to a rotary mixer (Dynal), and incubated at 37°C under continuous rotation for 45 min. After this secretion period, cells were centrifuged, resuspended in cold PBS buffer, and labeled with phycoerythrin-conjugated anti-IFN
detection Ab (Miltenyi), rat anti-mouse CD4 (Clone CT-CD4) conjugated to fluorescein isothiocyanate, and rat anti-mouse CD8
(Clone CT-CD8
) conjugated to allophycocyanin (all from Caltag). Dead cells were excluded from flow cytometric analysis by the addition of propidium iodide at 0.5 mg/L (BD Pharmingen). Cells were analyzed on a FACSvantage flow cytometer (BD Bioscience). Data collected on a minimum of 50,000 live cells per sample were analyzed using CellQuest software (version 3.1, BD Pharmingen).
Adoptive transfer of immunity. Donor cells were isolated from mice fed experimental diets for 4 wk and then adoptively transferred into recipients maintained on a commercial ration low in (n-3) PUFA diet (i.e., Purina 5008 Rodent Chow). PBS or crude effector lymphocytes (i.e., 5 x 107 splenocytes isolated from mice 7 d postchallenge) were injected into a lateral tail vein of age- and sex-matched naive BALB/c mice. Within 1 h of cell transfer, all recipient mice received 5 x 104 CFU of wild-type L. monocytogenes (10403S), a dose equivalent to the 50% lethal dose (LD50) for a naive BALB/c mouse (28). After 36 h, bacterial loads in the spleen and liver were determined by plate counts.
Statistical analysis.
Data were analyzed and graphed using GraphPad Prism, version 3.0a (GraphPad Software). The effect of dietary fat source on IFN
secretion was analyzed by unpaired t test. The organ bacterial load data were log10 transformed prior to analysis. The effects of dietary fat source and immunization on recipient bacterial load and other variables were analyzed using 2-way ANOVA with the Bonferroni post hoc test. P < 0.05 was considered significant.
| RESULTS |
|---|
|
|
|---|
production by splenic CD4+ and CD8+ T cells.
(n-3) PUFA had no impact on the final body weight of these mice (Table 1). Mice allowed to recover from the primary infection continued to grow normally through 35 d postchallenge. Spleen weight at both 7 and 35 d postchallenge was substantially greater for mice fed (n-3) PUFA compared to those fed the lard diet. At 35 d following the initial infection, the spleens of mice fed the lard-containing diet had returned nearly to normal size, whereas those from fish oilfed mice remained substantially enlarged (Table 1). Total splenic cell yield was greater in (n-3) PUFA mice at 35 d postchallenge than in lard-fed mice at this time (P < 0.05). Finally, (n-3) PUFA did not affect the percentage of splenic CD4+ T lymphocytes that produced IFN
in response to a noncognate stimuli (i.e.,
-CD3/
-CD28) from mice either 7 or 35 d postchallenge with L. monocytogenes. In contrast, the percentage of splenic CD8+ T lymphocytes that produced IFN
in response to
-CD3/
-CD28 stimulation from mice 7 but not 35 d postchallenge was diminished by (n-3) PUFA (P < 0.05).
|
secretion by CD4+ and CD8+ T cells.
We used ex vivo antigen (Ag)-stimulated IFN
production to determine whether pathogen-specific T lymphocyte responses were altered by dietary (n-3) PUFA. Spleens were harvested from diet-manipulated mice 7 or 35 d postchallenge to obtain effector and memory/effector T cell populations, respectively. Splenocytes were cultured overnight with Listeria-infected APCs to elicit IFN
production, which was measured using a commercial cytokine secretion assay. IFN
was not produced when uninfected APCs were used or when naive splenocytes were cocultured with Listeria-infected APCs (Fig. 1A, inset). In contrast, when APCs were infected with L. monocytogenes and cocultured with lymphocytes isolated from mice infected with L. monocytogenes either 7 or 35 d previously (Fig. 1A), we noted substantial numbers of IFN
-producing CD4+ and CD8+ T cells (i.e.,
2% of live cells). There were also large numbers of IFN
-producing cells that did not stain positive for CD4 or CD8
and were presumably natural killer cells. The frequencies of CD4+IFN
+ and CD8+IFN
+ effector T cells isolated from mice 7 d postchallenge were not affected by (n-3) PUFA (Fig. 1B and C). The absolute numbers of CD4+IFN
+ and CD8+IFN
+ effector T cells were also not affected by dietary fat source (data not shown). The absolute cell number data were calculated by multiplying the percentage of CD4+IFN
+ or CD8+IFN
+ cells by the spleen cell yield. When memory T cells were isolated from mice 35 d postchallenge, the diet rich in (n-3) PUFA was associated with lower frequencies of CD4+IFN
+ and CD8+IFN
+ memory/effector T cells (Fig. 2A and B, P < 0.01). However, when these data were expressed as the absolute number of CD4+ and CD8+ T cells per spleen that produced IFN
, the 2 diet groups did not differ (Fig. 2C and D).
|
|
1 log10) to clear bacteria from both the spleen and the liver (Fig. 3, P < 0.001). However, bacterial clearance did not differ between dietary groups. The data shown in Figure 3 are from 1 of 2 independent experiments with similar results obtained in both studies.
|
| DISCUSSION |
|---|
|
|
|---|
We assessed pathogen-specific T lymphocytes using ex vivo IFN
production as a marker for effector and memory/effector T cells (2931). Previously, we reported that (n-3) PUFA feeding had no effect on ex vivo, Listeria-specific IFN
production by splenocytes (23). However, the stimulation of splenocytes in bulk culture does not permit the contribution of different lymphocyte subsets to be distinguished. In this report, we used flow cytometry to measure Listeria-specific IFN
production by CD4+ and CD8+ effector and memory/effector T cells isolated at 7 and 35 d postchallenge, respectively. Our new results indicate that high (n-3) PUFA intake prior to and during a primary infection in mice with L. monocytogenes does not alter the frequency or absolute number of Listeria-specific CD4+ and CD8+ effector T cells in the spleen 7 d postchallenge. In contrast to the antigen-driven response, nonspecific IFN
production by CD8+ T cells stimulated by
CD3/
CD28 was diminished by (n-3) PUFA intake (25%, P < 0.05). Stimuli-dependent modulation of T cell proliferation by (n-3) PUFA has been reported previously (32,33). Caution should be exercised when interpreting data from (n-3) PUFA studies that use different T cell stimuli.
In contrast to effector T cells, Listeria-specific memory T cell development and/or survival appeared to be modestly affected by (n-3) PUFA. The exact mechanisms involved in memory cell differentiation are poorly understood, but memory cells are believed to derive from antigen-specific effector CD4+ and CD8+ T lymphocytes that survive growth factorinduced clonal contraction (34,35). The number of memory T cells generated is closely correlated with the extent of effector cell proliferation during the primary response (36). At 35 d postchallenge, mice fed the high (n-3) PUFA diet were found to have a 3050% lower frequency of Listeria-specific CD4+ and CD8+ memory/effector T cells in the spleen. However, the absolute number of Listeria-specific CD4+ and CD8+ memory/effector T cells per spleen at 35 d postchallenge did not differ between diet treatment groups. This apparent paradox can be explained in part because of the impact that consuming a (n-3) PUFA-rich diet has on spleen size and cellularity following a primary infection with L. monocytogenes.
In our study we noted that compared to mice fed an (n-3) PUFA-free diet, fish oilfed mice have heavier spleens with more immune cells in them at 35 d postchallenge. Splenomegaly associated with fish oil feeding in mice has been reported previously (19,37). This increase in spleen size is associated with increased cellularity, with little or no gross effect on the proportion of cell types found. In contrast, fish oil feeding of rats substantially increased splenic red pulp as well as macrophages and B cell numbers (38). In the context of diet manipulation of host infectious disease resistance, the absolute number of effector and effector/memory cells may have more physiologic relevance than relative abundance (i.e., percentage of cells). However, a limitation of the present work is our reliance on the spleen as a sole source of immune cells for T cell analysis. After resolution of a L. monocytogenes infection, the spleen contains only a small percentage of the memory T cells generated in vivo, with large numbers residing in the liver, lungs, and lamina propria of the small intestine (10). Thus it is possible that dietary (n-3) PUFA affected T cell responses in one of these other compartments, but not in the spleen. In the future, we hope to investigate the impact of (n-3) PUFA on T cell development throughout the body.
Our use of whole animals to study nutrient modulation of T cell development and function in vivo is one of the major strengths of this study. The immune response to infection involves a complex network of host cells and humoral factors, which cannot be readily reproduced in vitro (39). During in vivo immune responses participating cells change over time due to cell migration as well as through activation/differentiation processes. Inflammation and infection alter immune cell trafficking through the expression of various adhesion molecules on the surface of vascular endothelial cells (40). The expression of adhesion molecules on endothelial cells as well as on lymphocytes can be affected by dietary (n-3) PUFA (4143). Such changes resulted in reduced adherence between these 2 cell populations in vitro. Feeding rats a diet rich in (n-3) PUFA from fish oil diminished neutrophil trafficking to the lungs following an in vivo endotoxin challenge (44). Although these data are intriguing, little is known about whether, and how, diet (n-3) PUFA intake might affect T cell trafficking in vivo.
It has been over 40 y since lymphocytes were first shown to be indispensable for immunity to L. monocytogenes (45,46). The protective effect is associated mostly with the cytolytic activity of CD8+ T cells, because cells from IFN
-knockout mice can transfer protective immunity (47), whereas cells from perforin-knockout mice cannot (48). We used this well-characterized and biologically relevant approach to assess the impact of (n-3) PUFA on the generation of in vivo cytotoxic T lymphocyte (CTL) activity. Effector spleen cells were generated in vivo under conditions that were either rich or poor in (n-3) PUFA. These effector T cells were adoptively transferred to naive recipients fed a control diet [i.e., low in (n-3) PUFA] just prior to a challenge with a high dose of wild-type L. monocytogenes. As expected, substantial protection was afforded to mice receiving effector cells. However, there was no indication that the presence of a (n-3) PUFA-rich environment during effector T cell development adversely affected the in vivo cytolytic function of these cells in recipient mice. These results are consistent with our previous findings that (n-3) PUFA have little to no impact on the generation of immunological protection within the same host (23). Similarly, we previously reported that ex vivo, anti-viral CTL activity in the spleen 7 d following a vaccinia virus challenge was similar in mice fed a diet rich in (n-3) or (n-6) PUFA from fish oil and corn oil, respectively (49). In contrast, others have reported that dietary (n-3) PUFA diminish ex vivo anti-viral CTL (50). Feeding mice a diet containing (n-3) PUFA from fish oil decreased specific lysis of influenza-infected target cells by 50%. Further, addition of unsaturated, but not saturated, free fatty acids to the culture medium of a CTL clone decreased CTL degranulation dose-dependently as measured by esterase release (51). The underlying reason(s) for these discrepancies is unclear at the present time. However, our data suggest that caution should be exercised in the interpretation of in vitro fatty acid immune modulation studies.
In summary, to our knowledge this is the first report to directly investigate the potential impact of (n-3) PUFA on the in vivo proliferation and differentiation of naive CD8+ T cells. Our data provide strong evidence that, despite severely impairing primary host resistance against L. monocytogenes, dietary (n-3) PUFA do not substantially affect the in vivo adaptive immune response. Rather, the diminished host resistance that accompanies high (n-3) PUFA intake in mice must primarily be a consequence of changes in the innate immune system. Future studies will focus on identifying the specific defects in innate immune cell function that are both necessary and sufficient to cause the (n-3) PUFA-mediated reduction in host defense against this common food-borne pathogen.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supported in part by U.S. Department of Agriculture Grant 0035200-9115 and by the University of Missouris Food-for-the-21st-Century Program. ![]()
3 Current address: National Cancer Institute, Rockville, MD 20892. ![]()
5 Abbreviations used: Ag, antigen; APC, antigen presenting cell; CFU, colony-forming unit; CTL, cytotoxic T lymphocyte; IL, interleukin; MHC, major histocompatibility complex. ![]()
Manuscript received 9 January 2005. Initial review completed 31 January 2005. Revision accepted 21 February 2005.
| LITERATURE CITED |
|---|
|
|
|---|
1. Crum, N. F. (2002) Update on Listeria monocytogenes infection. Curr. Gastroenterol. Rep. 4:287-296.[Medline]
2. Benshushan, A., Tsafrir, A., Arbel, R., Rahav, G., Ariel, I. & Rojansky, N. (2002) Listeria infection during pregnancy: A 10 year experience. Isr. Med. Assoc. J. 4:776-780.[Medline]
3. Donnelly, C. W. (2001) Listeria monocytogenes: A continuing challenge. Nutr. Rev. 59:183-194.[Medline]
4. Milon, G. (1997) Listeria monocytogenes in laboratory mice: A model of short-term infectious and pathogenic processes controllable by regulated protective immune responses. Immunol. Rev. 158:37-46.[Medline]
5. Edelson, B. T. & Unanue, E. R. (2000) Immunity to Listeria infection. Curr. Opin. Immunol. 12:425-431.[Medline]
6. Czuprynski, C. J. & Haak-Frendscho, M. (1997) Non-specific resistance mechanisms to listeriosis: implications for experimental and naturally occurring infection. Immunol. Rev. 158:47-56.[Medline]
7. Unanue, E. R. (1997) Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158:11-25.[Medline]
8. Mackaness, G. B. (1962) Cellular resistance to infection. J. Exp. Med. 116:381-406.[Abstract]
9. Kaufmann, S. H. (1988) Listeria monocytogenes specific T-cell lines and clones. Infection 16(suppl. 2):S128-S136.
10. Pope, C., Kim, S. K., Marzo, A., Masopust, D., Williams, K., Jiang, J., Shen, H. & Lefrancois, L. (2001) Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J. Immunol. 166:3402-3409.
11. Yaqoob, P. (2003) Lipids and the immune response: From molecular mechanisms to clinical applications. Curr. Opin. Clin. Nutr. Metab. Care 6:133-150.[Medline]
12. Wu, D. (2004) Modulation of immune and inflammatory responses by dietary lipids. Curr. Opin. Lipidol. 15:43-47.[Medline]
13. Blok, W. L., Katan, M. B. & van der Meer, J.W.M. (1996) Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J. Nutr. 126:1515-1533.
14. James, M. J., Gibson, R. A. & Cleland, L. G. (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 71:343S-348S.
15. Calder, P. C., Yaqoob, P., Thies, F., Wallace, F. A. & Miles, E. A. (2002) Fatty acids and lymphocyte functions. Br. J. Nutr. 87(suppl. 1):S31-S48.
16. Anderson, M. & Fritsche, K. L. (2002) (N-3) fatty acids and infectious disease resistance: A critical review. J. Nutr. 132:3566-3576.
17. Fritsche, K. L., Shahbazian, L. M., Feng, C. & Berg, J. N. (1997) Dietary fish oil reduces survival and impairs bacterial clearance in C3H/Hen mice challenged with Listeria monocytogenes. Clin. Sci. 92:95-101.[Medline]
18. Puertollano, M. A., de Pablo, M. A. & Alvarez de Cienfuegos, G. (2001) Immunomodulatory effects of dietary lipids alter host natural resistance of mice to Listeria monocytogenes infection. FEMS Immunol. Med. Micro. 32:47-52.
19. Huang, S. C., Misfeldt, M. L. & Fritsche, K. L. (1992) Dietary fat influences Ia antigen expression and immune cell populations in the murine peritoneum and spleen. J. Nutr. 122:1219-1231.
20. Fritsche, K. L., Byrge, M. & Feng, C. (1999) Dietary omega-3 polyunsaturated fatty acids from fish oil reduce interleukin-12 and interferon-gamma production in mice. Immunol. Lett. 65:167-173.[Medline]
21. Buchmeier, N. A. & Schreiber, R. D. (1985) Requirement of endogenous interferon-
production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. U.S.A. 82:7404-7408.
22. Tripp, C. S., Gately, M. K., Hakimi, J., Ling, P. & Unanue, E. R. (1994) Neutralization of IL-12 decreases resistance to listeria in scid and c.b-17 mice. J. Immunol. 152:1883-1887.[Abstract]
23. Irons, R., Anderson, M. J., Zhang, M. & Fritsche, K. L. (2003) Dietary fish oil impairs primary host resistance against Listeria monocytogenes more than the immunological memory response. J. Nutr. 133:1163-1169.
24. Reeves, P. G., Nielsen, F. H. & Fahey, G. C. (1993) AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123:1939-1951.
25. Skoble, J., Portnoy, D. A. & Welch, M. D. (2000) Three regions within ActA promote Arp2/3 complex-mediated actin nucleation and Listeria monocytogenes motility. J. Cell. Biol. 150:527-538.
26. Auerbuch, V., Lenz, L. L. & Portnoy, D. A. (2001) Development of a competitive index assay to evaluate the virulence of Listeria monocytogenes actA mutants during primary and secondary infection of mice. Infect. Immun. 69:5953-5957.
27. McGuire, S. O., Alexander, D. W. & Fritsche, K. L. (1997) Fish oil source differentially affects rat immune cell
-tocopherol concentration. J. Nutr. 127:1388-1394.
28. North, R. J., Dunn, P. L. & Conlan, J. W. (1997) Murine listeriosis as a model of antimicrobial defense. Immunol. Rev. 158:27-36.[Medline]
29. London, C. A., Lodge, M. P. & Abbas, A. K. (2000) Functional responses and costimulator dependence of memory CD4+ T cells. J. Immunol. 164:265-272.
30. Kaech, S. M. & Ahmed, R. (2001) Memory CD8+ T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:415-422.[Medline]
31. Badovinac, V. P., Messingham, K. A., Hamilton, S. E. & Harty, J. T. (2003) Regulation of CD8+ T cells undergoing primary and secondary responses to infection in the same host. J. Immunol. 170:4933-4942.
32. Jenski, L. J., Scherer, J. M., Caldwell, L. D., Ney, V. A. & Stillwell, W. (1998) The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro. Lipids 33:869-878.[Medline]
33. Arrington, J. L., McMurray, D. N., Switzer, K. C., Fan, Y. Y. & Chapkin, R. S. (2001) Docosahexaenoic acid suppresses function of the CD28 costimulatory membrane receptor in primary murine and Jurkat T cells. J. Nutr. 131:1147-1153.
34. Mercado, R., Vijh, S., Allen, S. E., Kerksiek, K., Philip, I. M. & Pamer, E. G. (2000) Early programming of T cell populations responding to bacterial infection. J. Immunol. 165:6833-6839.
35. Sprent, J. & Tough, D. F. (2001) T cell death and memory. Science 293:245-248.
36. Hou, S., Hyland, L., Ryan, K. W., Portner, A. & Doherty, P. C. (1994) Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 369:652-654.[Medline]
37. Huang, S. C. & Fritsche, K. L. (1992) Alteration in mouse splenic phospholipid fatty acid composition and lymphoid cell populations by dietary fat. Lipids 27:25-32.[Medline]
38. Blok, W. L., de Bruijn, M.F.T.R., Leenen, P.J.M., Eling, W.M.C., Van Rooijen, N., Stanley, E. R., Buurman, W. A. & van der Meer, J.W.M. (1996) Dietary n-3 fatty acids increase spleen size and post-endotoxin circulating TNF in mice: Role of macrophages, macrophage precursors, and colony-stimulating factor-1. J. Immunol. 157:5569-5573.[Abstract]
39. Keil, D., Luebke, R. W. & Pruett, S. B. (2001) Quantifying the relationship between multiple immunological parameters and host resistance: Probing the limits of reductionism. J. Immunol. 167:4543-4552.
40. Hamann, A. & Syrbe, U. (2000) T-cell trafficking into sites of inflammation. Rheumatology (Oxford) 39:696-699.
41. Wahle, K. W. & Rotondo, D. (1999) Fatty acids and endothelial cell function: Regulation of adhesion molecule and redox enzyme expression. Curr. Opin. Clin. Nutr. Metab. Care 2:109-115.[Medline]
42. Khalfoun, B., Thibault, G., Bardos, P. & Lebranchu, Y. (1996) Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion. Transplantation 62:1649-1657.[Medline]
43. Sanderson, P. & Calder, P. C. (1998) Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 94:79-87.[Medline]
44. Mancuso, P., Whelan, J., DeMichele, S. J., Snider, C. C., Guszcza, J. A. & Karlstad, M. D. (1997) Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit. Care Med. 25:1198-1206.[Medline]
45. Miki, K. & Mackaness, G. B. (1964) The passive transfer of acquired resistance to Listeria monocytogenes. J. Exp. Med. 120:93-103.[Abstract]
46. Lane, F. C. & Unanue, E. R. (1972) Requirement of thymus (T) lymphocytes for resistance to listeriosis. J. Exp. Med. 135:1104-1112.[Abstract]
47. Harty, J. T., Lenz, L. L. & Bevan, M. J. (1996) Primary and secondary immune responses to Listeria monocytogenes. Curr. Opin. Immunol. 8:526-530.[Medline]
48. Kagi, D., Ledermann, B., Burki, K., Hengartner, H. & Zinkernagel, R. M. (1994) CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol. 24:3068-3072.[Medline]
49. Fritsche, K. F. & Johnston, P. V. (1990) Effect of dietary omega-3 fatty acids on cell-mediated cytotoxic activity in BALB/C mice. Nutr. Res. 10:577-588.
50. Byleveld, M., Pang, G., Clancy, R. & Roberts, D. (2000) Fish oil feeding enhances lymphocyte proliferation but impairs virus-specific T lymphocyte cytotoxicity in mice following challenge with influenza virus. Clin. Exp. Immunol. 119:287-292.[Medline]
51. Richieri, G. V., Mescher, M. F. & Kleinfeld, A. M. (1990) Short term exposure to cis unsaturated free fatty acids inhibits degranulation of cytotoxic T lymphocytes. J. Immunol. 144:671-677.[Abstract]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||